Ozempic

Topic

Ozempic is a brand name for semaglutide, an anti-diabetic medication developed by Novo Nordisk that is used for the treatment of type 2 diabetes. It functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to lower blood sugar levels and reduce the risk of major cardiovascular events. It is also widely known and prescribed off-label for chronic weight management.